Keyphrases
COVID-19
100%
Pyruvate Kinase Deficiency
44%
Hematological Malignancies
39%
Adult Patients
32%
Patients with Hematological Malignancies
28%
Mitapivat
26%
SARS-CoV-2 Infection
22%
Human Neutrophil Antigens
22%
Hemoglobin
22%
Sickle Cell Anemia
20%
Hemoglobin A1c (HbA1c)
20%
Hematology
18%
Sickle Cell Disease
17%
Autoimmune Neutropenia
16%
Early childhood
16%
Chronic Lymphocytic Leukemia
16%
Hemoglobin Variant
16%
Defensin
15%
High Risk
15%
Comorbidity
15%
Myelodysplastic Syndrome
14%
Mortality Rate
14%
Denmark
13%
Anemia
12%
Pyruvate Kinase
12%
Eosin-5-maleimide
12%
Leukemia Patients
11%
Hemoglobinopathies
11%
Hospitalization
11%
Confidence Interval
11%
Genotype
11%
Hemolytic Disease
11%
Splenectomy
11%
Vaccinated Patients
10%
National Cohort Study
10%
Neutrophils
10%
Retrospective Cohort Study
10%
Acute Myeloid Leukemia
10%
Evans Syndrome
10%
Nirmatrelvir
10%
Screening Program
10%
Myelopoiesis
10%
Bounds Test
10%
Immunization
10%
Patients with Cancer
10%
Whole Genome Sequencing
10%
Paired Analysis
10%
CCAAT/enhancer-binding Protein Homologous Protein
10%
Serine Protease
10%
COVID-19 Risk
10%
Medicine and Dentistry
COVID-19
92%
Infection
49%
Pyruvate Kinase Deficiency
48%
Disease
40%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Hematologic Malignancy
33%
Sickle-Cell Disease
28%
Mitapivat
26%
Hematology
17%
Prevalence
16%
Anemia
15%
B-Cell Chronic Lymphocytic Leukemia
15%
Evans Syndrome
15%
Hemolytic Anemia
14%
Symptom
14%
Neutrophil
13%
Hemolytic
13%
Hemoglobinopathy
13%
Sulfhemoglobinemia
12%
Pyruvate Kinase
12%
Mortality Rate
11%
Splenectomy
11%
Autoimmune neutropenia
11%
Cohort Analysis
11%
Retrospective Cohort Study
10%
Screening
10%
Oncology
10%
Whole Genome Sequencing
10%
Placebo
10%
Congenital Hemolytic Anemia
9%
Erythrocyte
9%
Overall Survival
8%
Acute Myeloid Leukemia
8%
Myelodysplastic Syndrome
8%
Cancer
7%
Arm
7%
Iron Overload
7%
Heart Failure
6%
Iron Metabolism
6%
Biological Marker
6%
Severe Acute Respiratory Syndrome
6%
Adenosine Triphosphate
6%
Intensive Care Unit
6%
Eosin
6%
Next Generation Sequencing
6%
Maleimide
6%
Malignant Neoplasm
6%
Erythropoietin
6%
Jaundice
6%
Patient-Reported Outcome
6%
